Get the weekly note
ETFIQetfiq.com · independent ETF data

MNTL Tema Neuroscience and Mental Health ETF

Tracks therapeutics and medical devices

MNTL has not filed its holdings yet, so there is nothing to look through.

Tema · Thematic ETFs · data as of

Key facts

not filedAlready in the S&P 500
not filedActive share vs the S&P 500
not publishedTop ten holdings
0.0%Total return, since launch

Method

7th of 9 therapeutics and medical devices ETFs by net assets

Its price barely moved. MNTL closed unchanged on 89 of its 90 trading days. A price that does not move is a price nobody traded at, so the figures above describe the days somebody did trade rather than what the fund did, and ETFIQ does not rank it against funds that trade every day. That is why it carries no Off-Index Score score: a fund outside the set has no score rather than a low one.

Method

Period by period

MNTL over each window to Sep 11, 2026. Every figure is an ETFIQ calculation. Source: ETFIQ.
WindowTotal returnS&P 500Gap to S&P 500Gap to Nasdaq-100
3 months0.0%+3.3%−3.3 pts+0.8 pts
6 months0.0%+15.4%−15.4 pts−20.0 pts
Since launch0.0%+11.3%−11.3 pts−17.5 pts

Method

In plain words

Since it launched on Feb 6, 2026 the fund returned 0.0% with distributions reinvested against +11.3% for the S&P 500, so a holder was behind by 11.3 pts.

MNTL (Tema Neuroscience and Mental Health ETF), thematic ETFs fields as of Sep 11, 2026. Source: ETFIQ.
Theme (ETFIQ, editorial)Therapeutics and medical devices
LaunchedFeb 6, 2026
Below its all-time high (ETFIQ)0.0%
Expense ratio (485BPOS XBRL, Jun 26, 2025)0.75%

Holdings from the fund’s latest public SEC N-PORT filing; overlap and active share computed by ETFIQ against the IVV and QQQM books; returns from Tiingo end-of-day prices with distributions reinvested. How these figures are computed

Questions people ask

Has MNTL beaten the S&P 500?
Over the year to Sep 11, 2026 MNTL returned 0.0% with distributions reinvested, against +11.3% for the S&P 500, so it finished behind the index by 11.3 points.
What does MNTL cost?
The prospectus expense ratio is 0.75% a year.

The words on this page

Active share
The part of the fund doing something the index is not, as a percentage. It is the part a fee is actually buying.
Weight overlap
The share of money two portfolios hold in the same securities at the same weight. Above 50%, holding both is close to holding one of them twice.
Already in the index
The fund’s weight in securities the S&P 500 holds at all. A fund can be made entirely of index names and still have high active share, because it holds them at very different weights.
Top ten
What the ten largest positions add up to. The higher it is, the more the fund is a bet on a few companies rather than a theme.

Every term used here, defined in full on the thematic ETFs vocabulary page.

Where these figures came from

ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.

Funds near this one

Put this on your own page

The difference bar for MNTL, redrawn every trading night. Free to use with the credit link.

MNTL difference bar, ETFIQ

Copy the embed code
<a href="https://etfiq.com/funds/MNTL"><img src="https://etfiq.com/embed/themes/MNTL.svg" alt="MNTL difference bar, ETFIQ" width="640"></a>
<p><a href="https://etfiq.com/funds/MNTL">MNTL difference bar, updated daily by ETFIQ</a></p>

Where MNTL is written about

MNTL, Thematic ETFs, ETFIQ, data as of Sep 11, 2026. Every figure is arithmetic on a named public source; the method is at etfiq.com/methodology. ETFIQ is an independent publisher, is not a fund issuer, broker-dealer or investment adviser, and makes no recommendations.
Use this data, or open the live card

Open MNTL live on ETFIQ, where the figures refresh with the data.

Cite this page. ETFIQ, MNTL, thematic ETFs, data as of Sep 11, 2026. https://etfiq.com/funds/MNTL Free to use with attribution; the underlying files are at Open data.

How these figures are computed · Standards and sources